Lidija Jovanovic

37 Kent Street
Brisbane, QLD 4102, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.

The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.

Journal: PeerJ

Published: July 05, 2019

Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Journal: Oncogene

Published: December 05, 2018

A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Journal: Oncogene

Published: January 29, 2018

Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.

Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.

Journal: The Prostate

Published: July 10, 2017

Impact of label-free technologies in head and neck cancer circulating tumour cells.

Impact of label-free technologies in head and neck cancer circulating tumour cells.

Journal: Oncotarget

Published: July 22, 2016

A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.

A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.

Journal: Oncogene

Published: November 13, 2015

Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop.

Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop.

Journal: Oncotarget

Published: August 09, 2015

Heterogeneity of miR-10b expression in circulating tumor cells.

Heterogeneity of miR-10b expression in circulating tumor cells.

Journal: Scientific reports

Published: February 17, 2015

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 05, 2014

PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.

PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.

Journal: Nanomedicine (London, England)

Published: November 20, 2014

Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.

Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.

Journal: Oncotarget

Published: October 04, 2014

Tie-2 regulates the stemness and metastatic properties of prostate cancer cells.

Tie-2 regulates the stemness and metastatic properties of prostate cancer cells.

Journal: Oncotarget

Published: June 23, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026